Company Overview and News

 
Trade tariffs hit ASX as resource stocks fall

2018-09-18 theage.com.au
Australian shares closed the session lower on Tuesday as the announcement on further tariffs on China hit major materials and energy stocks.
WOPEF BLT SGQ OGFGY REG RSG BEPTF GALXF RMGGF WNARF WSA AOG BHPBF WTCHF WPL BCHEY WOPEY BPT GXY RMGGY BHP BBL BHP OGFGF BHPLF JRHHY EHE JHC ORG

 
Trade tariffs hit ASX as resource stocks fall

2018-09-18 smh.com.au
Australian shares closed the session lower on Tuesday as the announcement on further tariffs on China hit major materials and energy stocks.
WOPEF BLT SGQ OGFGY REG RSG BEPTF GALXF RMGGF WNARF WSA AOG BHPBF WTCHF WPL BCHEY WOPEY BPT GXY RMGGY BHP BBL BHP OGFGF BHPLF JRHHY EHE JHC ORG

 
ASX set to open flat as trade angst returns

2018-09-16 theage.com.au
Australian stocks are poised to open flat, though gains could be checked by renewed US/China trade worries. ASX futures were at 6174 points early on Monday morning after Wall Street's benchmarks edged higher into the close.
PALAY PRU WOPEF PDN PFK TWODF WPL OGFGY BCHEY WOPEY PDN BEPTF BPT PALAF NDAQ PRH OGFGF TWODY PJH TW ORG

 
ASX set to open flat as trade angst returns

2018-09-16 smh.com.au
Australian stocks are poised to open flat, though gains could be checked by renewed US/China trade worries. ASX futures were at 6174 points early on Monday morning after Wall Street's benchmarks edged higher into the close.
PALAY PRU WOPEF PDN PFK TWODF WPL OGFGY BCHEY WOPEY PDN BEPTF BPT PALAF NDAQ PRH OGFGF TWODY PJH TW ORG

2
Energy sector lifts ASX to higher week

2018-09-14 theage.com.au
Australian shares have rebounded from last week's $50 billion fall to close the week higher despite some of the major financial stocks weighing the index.
WOPEF RIO RIO SNMYF EVN IAG OGFGY RSG BEPTF RTPPF GALXF SUN RMGGF RTNTF CAHPF MS IAUGY WTCHF SNMCY WPL RGRNF BCHEY WOPEY BPT GXY IAUGF RMGGY RIO RRL OGFGF ORG

2
Energy sector lifts ASX to higher week

2018-09-14 smh.com.au
Australian shares have rebounded from last week's $50 billion fall to close the week higher despite some of the major financial stocks weighing the index.
WOPEF RIO RIO SNMYF EVN IAG OGFGY RSG BEPTF RTPPF GALXF SUN RMGGF RTNTF CAHPF MS IAUGY WTCHF SNMCY WPL RGRNF BCHEY WOPEY BPT GXY IAUGF RMGGY RIO RRL OGFGF ORG

2
ASX closes lower as major insurers fall

2018-09-12 theage.com.au
The Australian sharemarkets recovery on Tuesday was short lived, with the market fall on Wednesday weighed down by a number of index heavyweights.
BGCHY MQBKY WOPEF RIO RIO SNMYF BGA SNMCY MCQEF WPL OGFGY WOPEY RTPPF RIO SUN RTNTF OGFGF MQG ORG

2
ASX closes lower as major insurers fall

2018-09-12 smh.com.au
The Australian sharemarkets recovery on Tuesday was short lived, with the market fall on Wednesday weighed down by a number of index heavyweights.
BGCHY MQBKY WOPEF RIO RIO SNMYF BGA SNMCY MCQEF WPL OGFGY WOPEY RTPPF RIO SUN RTNTF OGFGF MQG ORG

 
'Totally inappropriate': Gas giants to help research NT fracking industry impacts

2018-09-12 abc.net.au
The nation's five largest fracking companies are set to help measure the environmental impacts of fracking in the Northern Territory, presenting a "totally inappropriate" conflict of interest in the eyes of one thinktank.
OGFGF OGFGY ORG

 
ASX snaps eight-session losing streak as banks advance

2018-09-11 theage.com.au
Australian shares snapped an eight-session losing streak on Tuesday as banks and Telstra, along with a handful of miners, helped the market take back some losses made amid ongoing Sino-US trade tensions and turmoil in emerging markets.
2282 DB OISHY NAB NASXF MCHVF NABZY WHC OGFGY OISHF NAUBF MCHVY ARLUF ALL OGFGF ORG OSH

 
ASX snaps eight-session losing streak as banks advance

2018-09-11 smh.com.au
Australian shares snapped an eight-session losing streak on Tuesday as banks and Telstra, along with a handful of miners, helped the market take back some losses made amid ongoing Sino-US trade tensions and turmoil in emerging markets.
2282 DB OISHY NAB NASXF MCHVF NABZY WHC OGFGY OISHF NAUBF MCHVY ARLUF ALL OGFGF ORG OSH

6
RIU GoodOilConference Perth attracts oil and gas plays on the hunt for juniors

2018-09-11 proactiveinvestors.com.au
RIU GoodOilConference Perth kicks off tomorrow morning in East Perth, with a number of large and medium-sized companies attending to see what junior companies will be up to in the coming year.
PCL CVN HZN TAO SRNLY SUR LIO TAOIF OGFGY COP HZNFF BEPTF LIOEF COMRF CPTLY SHI WBC COI SNP STO ADXRF WEBNF WBK ADX BCHEY CVONF BPT RLE WBC CTP WEL HZR OGFGF ORG

6
RIU GoodOilConference Perth to start with market update from Argonaut director Michael Eidne

2018-09-11 proactiveinvestors.com.au
RIU GoodOilConference Perth kicks off tomorrow morning in East Perth, with Argonaut research director Michael Eidne delivering the low-down on the current state of the industry in his opening address.
PCL CVN HZN TAO SRNLY SUR LIO TAOIF OGFGY COP HZNFF BEPTF LIOEF COMRF CPTLY SHI WBC COI SNP STO ADXRF WEBNF WBK ADX BCHEY CVONF BPT RLE WBC CTP WEL HZR OGFGF ORG

2
Markets Live: ASX closes at lowest value since June

2018-09-10 theage.com.au
Below is William's market wrap. I will be back editing tomorrow. CSL is going ex-dividend tomorrow by 127.8 cents, and NAB's business conditions indicator will be out in the morning.
BGCHY RIO BLT RIO MAYNF OGFGY OISHF BEPTF RTPPF MYX RTNTF INCZY OSH PRY OISHY BHPBF BGA WTCHF BCHEY MYPHY PHCRY BPT PTM BHP RIO BBL PHCRF BHP OGFGF BHPLF ICPVF IPL ORG

2
Markets Live: ASX closes at lowest value since June

2018-09-10 smh.com.au
Below is William's market wrap. I will be back editing tomorrow. CSL is going ex-dividend tomorrow by 127.8 cents, and NAB's business conditions indicator will be out in the morning.
BGCHY RIO BLT RIO MAYNF OGFGY OISHF BEPTF RTPPF MYX RTNTF INCZY OSH PRY OISHY BHPBF BGA WTCHF BCHEY MYPHY PHCRY BPT PTM BHP RIO BBL PHCRF BHP OGFGF BHPLF ICPVF IPL ORG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 006214861